Prime Capital Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Buy |
73,219
+7,998
| +12% | +$552K | 0.07% | 197 |
|
|
2025
Q1 | $4.53M | Buy |
65,221
+2,609
| +4% | +$181K | 0.05% | 238 |
|
|
2024
Q4 | $5.39M | Sell |
62,612
-1,579
| -2% | -$136K | 0.08% | 172 |
|
|
2024
Q3 | $7.64M | Sell |
64,191
-9,497
| -13% | -$1.13M | 0.11% | 139 |
|
|
2024
Q2 | $10.5M | Sell |
73,688
-11,423
| -13% | -$1.63M | 0.16% | 109 |
|
|
2024
Q1 | $10.9M | Sell |
85,111
-23,515
| -22% | -$3.02M | 0.15% | 117 |
|
|
2023
Q4 | $11.2M | Buy |
108,626
+93,307
| +609% | +$9.65M | 0.17% | 115 |
|
|
2023
Q3 | $1.39M | Sell |
15,319
-787
| -5% | -$71.6K | 0.03% | 301 |
|
|
2023
Q2 | $1.3M | Buy |
16,106
+7,902
| +96% | +$639K | 0.03% | 312 |
|
|
2023
Q1 | $653K | Sell |
8,204
-136
| -2% | -$10.8K | 0.03% | 306 |
|
|
2022
Q4 | $564K | Buy |
8,340
+2,330
| +39% | +$158K | 0.02% | 313 |
|
|
2022
Q3 | $299K | Buy |
6,010
+108
| +2% | +$5.37K | 0.02% | 305 |
|
|
2022
Q2 | $329K | Sell |
5,902
-256
| -4% | -$14.3K | 0.02% | 282 |
|
|
2022
Q1 | $345K | Hold |
6,158
| – | – | 0.02% | 280 |
|
|
2021
Q4 | $345K | Buy |
6,158
+256
| +4% | +$14.3K | 0.02% | 280 |
|
|
2021
Q3 | $283K | Sell |
5,902
-1,002
| -15% | -$48K | 0.02% | 254 |
|
|
2021
Q2 | $289K | Sell |
6,904
-140
| -2% | -$5.86K | 0.02% | 313 |
|
|
2021
Q1 | $237K | Buy |
7,044
+5,780
| +457% | +$194K | 0.02% | 235 |
|
|
2020
Q4 | $44K | Sell |
1,264
-28
| -2% | -$975 | ﹤0.01% | 334 |
|
|
2020
Q3 | $45K | Sell |
1,292
-104
| -7% | -$3.62K | ﹤0.01% | 326 |
|
|
2020
Q2 | $46K | Buy |
1,396
+500
| +56% | +$16.5K | ﹤0.01% | 330 |
|
|
2020
Q1 | $27K | Sell |
896
-78
| -8% | -$2.35K | ﹤0.01% | 331 |
|
|
2019
Q4 | $28K | Sell |
974
-104
| -10% | -$2.99K | ﹤0.01% | 368 |
|
|
2019
Q3 | $28K | Buy |
+1,078
| New | +$28K | ﹤0.01% | 373 |
|